China News Service, Changchun, September 27th (Reporter Guo Jia) The 22nd Hope Marathon-a charity run for cancer patients and cancer prevention research was fired in Changchun on the 27th.
It is reported that all the donations raised in this charity run will be turned over to the China Cancer Foundation for the treatment of cancer patients and cancer prevention research.
Hope Marathon originated in Canada and came to China for the first time in 1999. After more than 20 years of development, it has become one of China's largest anti-cancer public welfare activities.
The event was sponsored by the National Cancer Center, Cancer Hospital of Chinese Academy of Medical Sciences, China Cancer Foundation, Jilin Provincial Cancer Hospital, and Jilin Provincial Cancer Center.
Affected by the new crown pneumonia epidemic, the activities were conducted in a combination of online and offline methods.
The event lasts for 13 days, and online participants can upload personal results through the mobile app.
The 22nd Hope Marathon-the scene of a charity run for cancer patients and cancer prevention research.
Guo Jiashe
On the same day, about a thousand people came to the high-tech campus of Jilin Cancer Hospital to participate in the offline charity run.
Among them, there are both socially caring people and cancer survivors.
"Anti-cancer star" Wang Xiaofeng ran 5 kilometers in one breath.
He said that long-distance running helped him build up his body and get rid of worries. He hoped that more people would join him.
Cheng Ying, secretary of the Party Committee of Jilin Cancer Hospital and director of the Jilin Cancer Center, said that it is hoped that the marathon will be held in Changchun for three years and will attract more than 4,600 caring people to participate and raise more than 1.1 million yuan.
Cheng Ying said that he hopes that the marathon will let cancer patients feel the attention and care from all walks of life, and that more people from all walks of life will join in and contribute their own strength to support the development of cancer prevention and research in China.
(Finish)